Find and Pitch Jounalists, Get Your Story Covered

Tags: gear gadget lab podcast podcasts drugs weight loss

	Profile	Recent Articles on Subject
1	Kristen Monaco MedPage Today	Liraglutide Helped Cut BMI in Kids With Obesity as Young as 6 - 9 days ago Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update - about 1 month ago Investigational Once-Monthly Injectable Boosts Response Rate in Acromegaly - about 2 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - about 2 months ago Few Stick With Ozempic; Pfizer Making Daily GLP-1; Once-Weekly Insulin Turned Down - 2 months ago Farxiga OK'd for Kids; Semaglutide Price Hearing; Maintaining GLP-1 Weight Loss - 3 months ago No Link Between GLP-1 Drugs and Suicide, Says European Regulator - 5 months ago Surgery May Be More Cost-Effective Than Wegovy in Adults With a BMI 35+ - 5 months ago Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? - 6 months ago Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes - 6 months ago Wegovy Approved for Heart Disease Prevention - 7 months ago Beware of Fake Ozempic, FDA Warns - 9 months ago Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industry - 9 months ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - 10 months ago Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis - 10 months ago Tirzepatide Wins FDA Approval for Weight Loss - 11 months ago Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids? - 11 months ago
2	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - 15 days ago Can you get satiety with GLP-1s without the nausea? - 2 months ago STAT+: Amgen goes all in on injectable obesity drug as it scraps early-stage pill - 5 months ago Eli Lilly gets FDA approval to sell Mounjaro as obesity drug called Zepbound - 11 months ago
3	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - 15 days ago STAT+: Eli Lilly reports tirzepatide MASH success during Q4 earnings - 8 months ago
4	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	SELECT Trial Shows Similar Cardiac Benefits of Semaglutide for Heart Failure - 28 days ago Study: Unexpected Safety Signals Identified for Semaglutide in Diabetes, Obesity - 2 months ago Teva Launches Generic Formulation of Liraglutide in US - 3 months ago Compounded, Counterfeit Semaglutide Poses Severe Risk to Patients - 5 months ago FDA Approves Semaglutide for New Indication Involving Cardiovascular Disease - 7 months ago FLOW Trial Results Demonstrate Positive Kidney Outcomes With Semaglutide - 7 months ago Investigational GLP-1 Medication Found to Reduce Body Weight - 7 months ago Proposed Biosimilar Liraglutide Shows Non-Inferiority to Reference Drug for Type 2 Diabetes - 9 months ago Tirzepatide Results in Superior Mean Percent Change in Body Weight for Those with Obesity - 9 months ago
5	Rick Lange, MD, Texas Tech; Elizabeth Tracey MedPage Today Texas Tech University System, advancing higher education and health care. Lubbock, Texas higher educationhealth care	New Firearm Injury Numbers; Another Indication for Semaglutide? - about 2 months ago Dulaglutide, Weight Gain, and Smoking Cessation; New Year's Eye Injuries - 9 months ago Live Shingles Vaccine and Waning Immunity; Semaglutide and CV Events - 10 months ago
6	Katie Palmer STAT News Health tech reporter @statnews. JSK Stanford alum. MA health technologysciencejournalism	Weight loss drugs without a prescription? Study warns it’s a ‘very risky business’ - about 2 months ago
7	Michael Calore Wired Editor at @WIRED, cohost @gadgetlab podcast. 94110 editingpodcasting	Semaglutide for the People - 2 months ago
8	Clare Wilson New Scientist Science news source. Worldwide sciencenewstechnology	Ozempic and Wegovy linked to lower risk of alcoholism - 3 months ago The science and side effects behind the semaglutide weight loss drugs - 8 months ago
9	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment - 3 months ago
10	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Study Finds Semaglutide Improves Chronic Kidney Disease in Patients With Type 2 Diabetes - 4 months ago

Journalists covering semaglutide